Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Prostate Specific Antigen”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01786265
What this trial is testing

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate Carcinoma
M.D. Anderson Cancer Center 310
Not applicableActive Not RecruitingNCT03234556
What this trial is testing

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

Who this might be right for
Health Status UnknownElevated PSA
University of Southern California 288
Testing effectiveness (Phase 2)Ended earlyNCT02420652
What this trial is testing

Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Rutgers, The State University of New Jersey 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Who this might be right for
Castration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more
OHSU Knight Cancer Institute 58
Testing effectiveness (Phase 2)Study completedNCT00082134
What this trial is testing

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Hormone-refractory Prostate Cancer
Genzyme, a Sanofi Company 40
Testing effectiveness (Phase 2)WithdrawnNCT05705700
What this trial is testing

Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)

Who this might be right for
Prostate Cancer
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)UnknownNCT00731848
What this trial is testing

Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Roll International Corporation 30
Testing effectiveness (Phase 2)Study completedNCT00054574
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01681433
What this trial is testing

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Who this might be right for
Prostate CancerMetastatic Castrate-Resistant Prostate CancerPSA
Costantine Albany 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Not applicableStudy completedNCT02228265
What this trial is testing

Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaProstate Adenocarcinoma+3 more
OHSU Knight Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT02429193
What this trial is testing

Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA

Who this might be right for
Castration-resistant Prostate Cancer
University Health Network, Toronto 16
Testing effectiveness (Phase 2)Study completedNCT00165399
What this trial is testing

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Who this might be right for
Adenocarcinoma of the ProstateProstate Cancer
Dana-Farber Cancer Institute 62
Testing effectiveness (Phase 2)Study completedNCT01162135
What this trial is testing

Digoxin for Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 16
Testing effectiveness (Phase 2)Looking for participantsNCT05751941
What this trial is testing

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 26
Not applicableStudy completedNCT02155998
What this trial is testing

Non-Interventional Study PREVENT

Who this might be right for
Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients
AstraZeneca 200
Post-approval studies (Phase 4)Ended earlyNCT00596453
What this trial is testing

Impact of Antibiotic Treatment on Prostate-Specific Antigen (PSA) Variability

Who this might be right for
Prostate Infections
Johns Hopkins University 31
Testing effectiveness (Phase 2)Ended earlyNCT02215161
What this trial is testing

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMetastatic Prostate Carcinoma in the Soft Tissue+3 more
University of California, San Francisco 14
Testing effectiveness (Phase 2)Ended earlyNCT01483586
What this trial is testing

Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer

Who this might be right for
Prostate Cancer
KangLaiTe USA 90
Large-scale testing (Phase 3)Active Not RecruitingNCT00567580
What this trial is testing

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,792
Load More Results